New York, New York--(Newsfile Corp. - November 11, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE: MOH) concerning possible violations of federal securities laws.On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its guidance for the third time this year, citing cost pressure and underperformance. The Company is now expecting earnings of $14 per share ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Wildermuth Fund due to allegations of violations of federal securities laws, encouraging affected investors to discuss their legal options [2][5]. Group 1: Legal Investigation and Claims - The firm is urging investors who suffered losses in the Wildermuth Fund between November 1, 2020, and June 29, 2023, to contact them for legal discussions [1]. - A federal securities class action has been filed against Wildermuth Fund, with a deadline of December 29, 2025, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that the Fund and its executives made false or misleading statements and failed to disclose critical information regarding the Fund's investments [5]. Group 2: Fund Performance and Management Changes - On June 29, 2023, the Fund's Board approved a liquidation plan based on the adviser's recommendation, despite reassurances about the underlying investments [6]. - Daniel and Carol Wildermuth resigned from their positions on November 1, 2023, and the agreement with the previous adviser was terminated, with BW Asset Management Ltd. appointed as the new investment adviser [7]. - By October 2024, the value of the Fund's investments had decreased by 63.6% compared to March 2022, and the net asset value (NAV) had declined by 73.7% [8].

Core Points - Levi & Korsinsky has initiated an investigation into Beyond Meat, Inc. for potential violations of federal securities laws [1] - Beyond Meat announced an expected non-cash impairment charge for the three months ending September 27, 2025, related to certain long-lived assets, which is anticipated to be material [1] - Following the announcement, Beyond Meat's stock price dropped over 23% on October 24, 2025 [1] Company Overview - Beyond Meat, Inc. is facing scrutiny due to its recent financial disclosures and the subsequent impact on its stock performance [1] - The investigation by Levi & Korsinsky highlights the firm's focus on protecting shareholder interests in cases of potential securities law violations [2]

Core Viewpoint - Berman Tabacco is investigating potential stockholder claims against Live Nation Entertainment, Inc. for allegedly deceiving consumers and violating federal law [1] Investigation Details - The Federal Trade Commission (FTC) and seven states filed a civil complaint against Live Nation and Ticketmaster, alleging systematic violations of federal law that generated hundreds of millions in revenue through deceptive practices [2] - The complaint highlights a specific incident where a broker used multiple accounts to purchase 9,000 tickets for a Beyonce concert, reselling 2,500 tickets at inflated prices, resulting in additional fees for Live Nation and Ticketmaster [2] Management Involvement - Allegations suggest that senior officers of Live Nation and Ticketmaster were complicit in the deception, instructing management to ignore ticket brokers bypassing enforcement measures [3] - Following the FTC's complaint, Live Nation's shares experienced a decline of approximately 3% [3] Board Investigation - Berman Tabacco is examining whether the board of directors of Live Nation played a role in the alleged scheme and if there were breaches of fiduciary duties by its officers and/or directors [4]

Core Insights - Molina Healthcare, Inc. is under investigation for possible violations of federal securities laws following disappointing earnings and guidance cuts [1][2] - The company reported third quarter fiscal 2025 earnings significantly below consensus, with an expected full-year earnings of $14 per share, down from a previous estimate of "no less than $19" [2] - Molina's stock price dropped by $38.08 to open at $157.05 per share after the earnings announcement [3] Financial Performance - Molina's third quarter earnings were well below market expectations, primarily due to cost pressures and underperformance in its marketplace business [2] - The company has revised its earnings guidance for the third time in 2025, indicating ongoing financial challenges [2] Stock Market Reaction - Following the earnings report, Molina's stock experienced a significant decline, reflecting investor concerns over the company's financial outlook [3]

Core Points - Berman Tabacco is investigating potential stockholder claims against SelectQuote, Inc. regarding allegations of illegal payments from health insurance providers [1] - Allegations suggest that SelectQuote received illegal payments exceeding 80 million dollars from Humana and Aetna between 2016 and 2021 to direct customers towards their Medicare offerings [2] - The investigation will examine the involvement of SelectQuote's board of directors and whether there were breaches of fiduciary duties by its officers and/or directors [3] Investigation Details - The allegations were unsealed in May 2025 after the U.S. Attorney's Office for the District of Massachusetts intervened, joining claims initially raised by a whistleblower [2] - Following the filing of the Department of Justice's complaint, SelectQuote's shares declined approximately 20% [2]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against KBR, Inc. related to alleged violations of federal securities laws, urging affected investors to contact them before the November 18, 2025 deadline for lead plaintiff applications in a federal class action lawsuit [1][3]. Group 1: Allegations Against KBR - The complaint alleges that KBR and its executives made false or misleading statements regarding the HomeSafe partnership, despite knowing about the U.S. Department of Defense's concerns about HomeSafe's ability to fulfill the Global Household Goods Contract [3]. - The lawsuit claims that KBR's statements about its business operations and prospects were materially false and misleading, leading to investor damages when the true information became public [3]. Group 2: Stock Price Impact - Following the announcement of the termination of the Global Household Goods Contract by HomeSafe on June 19, 2025, KBR's stock price fell by $3.85 per share, or 7.29%, closing at $48.93 on June 20, 2025 [4]. - On the next trading day, KBR's stock experienced an additional decline of $1.30, or 2.65%, closing at $47.63 on June 23, 2025 [4]. Group 3: Legal Process and Participation - The lead plaintiff in the class action is defined as the investor with the largest financial interest who is typical of class members and oversees the litigation on behalf of the class [5]. - Any member of the putative class can apply to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [5].

Core Insights - Hormel Foods Corporation is under investigation for possible violations of federal securities laws, as announced by Levi & Korsinsky [1] - Hormel Foods has cut its earnings forecast due to price pressures, bird flu, and a fire at its Arkansas peanut butter production facility, leading to a stock decline of over 9% on October 29, 2025 [2] Company Overview - Hormel Foods Corporation is facing significant challenges impacting its financial performance, including external pressures from market conditions and operational disruptions [2] - The company has recently parted ways with its Chief Financial Officer, indicating potential internal management issues [2] Legal Context - Levi & Korsinsky LLP, a recognized securities litigation firm, has initiated an investigation into Hormel Foods, highlighting the firm's history of securing substantial settlements for shareholders [3]

Core Viewpoint - A class action lawsuit has been filed against KBR, Inc. for allegedly making false and misleading statements regarding its partnership with the U.S. Department of Defense's Transportation Command, leading to investor losses during the specified Class Period [3][7]. Allegation Details - The lawsuit claims that KBR was aware of concerns from TRANSCOM about HomeSafe's ability to fulfill its Global Household Goods Contract for months but failed to disclose this information [3]. - KBR allegedly misled investors by asserting that its partnership with TRANSCOM would continue to grow despite these concerns [3]. - The company's public statements throughout the Class Period are claimed to be false and materially misleading, resulting in damages to investors when the truth was revealed [3]. Next Steps - Investors who purchased KBR shares between May 6, 2025, and June 19, 2025, and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 18, 2025 [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across the United States [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. due to alleged violations of federal securities laws, encouraging investors who suffered losses exceeding $75,000 to contact them directly [1][3]. Summary by Sections Legal Investigation - The law firm is looking into claims against Molina Healthcare, highlighting a deadline of December 2, 2025, for investors to seek the role of lead plaintiff in a federal securities class action [1][6]. Allegations Against Molina - The complaint alleges that Molina and its executives made false or misleading statements regarding: 1. Material adverse facts about the company's medical cost trend assumptions [3]. 2. A dislocation between premium rates and medical cost trends [3]. 3. Molina's near-term growth being dependent on low utilization of various health services [3]. 4. A substantial likelihood of cutting financial guidance for fiscal year 2025 [3]. 5. Misleading positive statements about the company's business and prospects [3]. Financial Performance and Stock Impact - On July 7, 2025, Molina announced second-quarter financial results, revealing adjusted earnings of approximately $5.50 per share, which was below prior expectations, leading to a 10.2% cut in full-year earnings guidance from at least $24.50 to a range of $21.50 to $22.50 per share [4]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share on July 7, 2025 [4]. - On July 23, 2025, Molina further slashed its full-year earnings guidance, reporting GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year, and cutting full-year adjusted earnings guidance to no less than $19.00 per diluted share, representing a 13.6% cut [5]. - This led to a significant drop in Molina's stock price by $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025 [5].